Immunohistochemical analyses revealed that tumors were negative for CC26, a Clara cell protein (Figure 3G) and positive for surfactant protein-C, a type II pneumocyte marker (Figure 3H), indicating that the tumor cells had a type II cell-like phenotype. The gene discussed is SFTPC; the disease is neoplasm.